PSMA PET Imaging and Prostate Cancer : Episode 2

Opinion

Video

January 30, 2024

The Utility of PSMA PET in Prostate Cancer

Author(s):

Expert oncologists give an overview of prostate-specific membrane antigen (PSMA) and discuss its utility for the treatment of prostate cancer.

Video Player is loading.

Current Time 0:00

Duration 4:42

Loaded: 0%

Stream Type LIVE

Remaining Time 4:42

EP: 1.The Evolution of Imaging Techniques in Prostate Cancer

Now Viewing

EP: 2.The Utility of PSMA PET in Prostate Cancer

EP: 3.Clinical Development of PSMA-Targeted Therapies

EP: 4.Clinical Practices of PSMA-Targeted Agents in Prostate Cancer

EP: 5.Multidisciplinary Approaches in PSMA PET for Prostate Cancer

EP: 6.Patient Profile 1: A 51-Year-Old Man with High-Risk Localized Prostate Cancer

EP: 7.PSMA PET Imaging and Clinical Perspectives from Patient Profile 1

EP: 8.LIGHTHOUSE Trial and The Role of 18F-rhPSMA-7.3 for Staging of Prostate Cancer

EP: 9.An Overview of the SPOTLIGHT Trial for PSMA PET in Prostate Cancer

EP: 10.SPOTLIGHT Trial and 18F-rhPSMA-7.3 for Prostate Cancer

EP: 11.Patient Profile 2: A 62-Year-Old Man with Recurrent Prostate Cancer

EP: 12.Patient Profile 3: A 67-Year-Old Male with Recurrent Prostate Cancer

EP: 13.Future Horizons in PSMA-Targeted Imaging and the Management of Prostate Cancer

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!

Recent Content

Blur image of hospital | Image Credit: © jakkapan - stock.adobe.com

What should the adult urologist know about pediatric urologic cancers?

FDA grants de novo authorization to ArteraAI Prostate

FDA grants priority review to gepotidacin for uncomplicated urogenital gonorrhea

Pearls & Perspectives: Bringing the Magic Back to Medicine, with David Canes, MD

View More Recent Content

Do not sell my Personnal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777